BANGKOK (AP) — Thailand’s House of Representatives on Thursday approved a bill that would allow the government to borrow up to 500 billion baht ($16 billion) to deal with the economic fallout and medical costs of the coronavirus.
About 300 billion baht ($9.6 billion) would be used for direct assistance to individuals and businesses, 170 billion baht ($5.5 billion) to create jobs and stimulate the economy, and 30 billion baht ($962 million) for medical equipment, research and medicine.
A decree last year allowed the government to borrow 1 trillion baht ($32 billion) for the same purposes. The government said the funding cushioned the economic blow from the pandemic, reducing the tourism-dependent economy's contraction to about 6% from projections that had been as high as 8%.
However, the government has been accused of a lack of transparency and mismanagement in utilizing those funds.
The House passed the new bill by a vote of 270-196, with three abstentions. The measure goes to the Senate on Monday, where it is expected to pass easily.
Finance Minister Arkhom Termpittayapaisith told Parliament on Wednesday that Thailand's economy is currently at its weakest since the 1997 Asian financial crisis.
“It will be too late if we wait for the annual budget in 2022,” he said. “The government needs money urgently to solve the COVID-19 situation and to restore confidence.”
Thailand has been battling a sharp surge in the coronavirus since April. Health authorities on Thursday announced 2,310 new cases, bringing the total to 187,538 since January last year, and 43 additional related deaths for a total of 1,375. More than 80% of the total cases and 90% of the deaths have occurred since April.
The government has been widely criticized for failing to secure adequate supplies of COVID-19 vaccines and for waiting until this week to launch mass vaccinations.
Before you consider ONE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ONE wasn't on the list.
While ONE currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.